We are live on ! Find out more
QNRX

Quoin Pharmaceuticals
QNRX

19 hedge funds and large institutions have $12.2M invested in Quoin Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

113,330% more capital invested

Capital invested by funds: $10.7K → $12.2M (+$12.2M)

280% more funds holding

Funds holding: 5 → 19 (+14)

100.21% more ownership

Funds ownership: 0.25% → 100.46% (+100%)

Holders
19
Holders Change
+14
Holders Change %
+280%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
4
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
+$2.88M
2
WP
Woodline Partners
California
+$1.08M
3
SCM
Stonepine Capital Management
Oregon
+$1.06M
4
Aberdeen Group
Aberdeen Group
United Kingdom
+$1.02M
5
Millennium Management
Millennium Management
New York
+$1.02M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
IC
1
Ikarian Capital
Texas
$3.05M +$2.88M +211,538 New
WP
2
Woodline Partners
California
$1.15M +$1.08M +79,582 New
SCM
3
Stonepine Capital Management
Oregon
$1.13M +$1.06M +78,189 New
Aberdeen Group
4
Aberdeen Group
United Kingdom
$1.08M +$1.02M +75,000 New
Millennium Management
5
Millennium Management
New York
$1.08M +$1.02M +74,817 New
SC
6
SummitTX Capital
Texas
$935K +$882K +64,795 New
BFM
7
Boothbay Fund Management
New York
$863K +$815K +59,838 New
ACM
8
ADAR1 Capital Management
Texas
$840K +$793K +58,230 New
ACM
9
AIGH Capital Management
Maryland
$712K +$671K +49,323 New
RCAP
10
Resolute Capital Asset Partners
Colorado
$433K +$408K +30,000 New
SCM
11
Soleus Capital Management
Connecticut
$361K +$340K +25,000 New
SAM
12
Simplify Asset Management
Nevada
$252K +$238K +17,448 New
CC
13
Centiva Capital
New York
$174K +$164K +12,053 New
Morgan Stanley
14
Morgan Stanley
New York
$43.3K +$40.8K +3,000 New
GI
15
GAMMA Investing
California
$30.1K +$24.6K +1,806 +650%
RhumbLine Advisers
16
RhumbLine Advisers
Massachusetts
$24K +$6.21K +456 +38%
SS
17
SBI Securities
Japan
$3.56K +$3.33K +245 +12,250%
UBS Group
18
UBS Group
Switzerland
$245 +$218 +16 +1,600%
HNB
19
Huntington National Bank
Ohio
$6 – – –

QNRX Hedge Fund Activity: Q4 2025 in Review

19 of the 8,226 institutional investors tracked by Wall St. Rank reported a position in Quoin Pharmaceuticals (QNRX) for Q4 2025, worth a combined $12.2M — up 113,330% from $10.7K a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new QNRX positions and 0 closed out — a net gain of 14 holders — while 4 added to existing stakes and 0 trimmed.

The largest buyer was Ikarian Capital, opening a new position worth an estimated $2.88M.

  • 19 institutional investors held Quoin Pharmaceuticals (QNRX) as of Q4 2025, up from 5 in Q3 2025.
  • Funds reported $12.2M of Quoin Pharmaceuticals stock for Q4 2025, up 113,330% quarter-over-quarter.
  • 14 funds opened new Quoin Pharmaceuticals positions in Q4 2025 and 0 closed out, a net change of +14 holders.
  • The largest Quoin Pharmaceuticals buyer in Q4 2025 was Ikarian Capital, an estimated $2.88M added.

Based on aggregated 13F filings for Q4 2025.